Afssaps crisis leads French minister to promise radical reform of drug regulation
This article was originally published in Scrip
Executive Summary
French health minister Xavier Bertrand has outlined a radical set of proposals for overhauling regulatory procedures at the national drug agency, Afssaps, in the wake of revelations that the agency failed to protect the public from the adverse cardiac effects of Servier's antidiabetic product, Mediator (benfluorex).